Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06804291 · ClinicalTrials.gov registry record · NA
The Effect of Cycling, Running, and Playing Rugby on Three Biomarkers That May Indicate Brain Injury
A NA study, sponsored by Appalachian State University.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT06804291 is a NA study that has completed, run by Appalachian State University. The registered enrollment target is 32 participants.
The verdict
NCT06804291, a NA study, has completed, sponsored by Appalachian State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The goal of this clinical trial was to determine if and how the biomarkers neurofilament light (NfL), brain lipid binding protein (BLBP), and amyloid precursor protein (APP) accumulated over 72 hours in venous blood following running, cycling, or playing rugby as compared to a non-exercising control group. Participants in this study were recreationally active and healthy males and females 18 - 49 years of age. The main questions it aimed to answer was: Do NfL, BLBP, and APP increase following exercise? Researchers compared the accumulation of NfL, BLBP, and NfL among runners, cyclists, rugby players, controls, and between sexes in each category. Participants were asked to either run, bike, play a rugby match, or abstain from exercise. In the exercising group, blood was drawn from a vein prior to the activity, immediately after the activity, 30 minutes after the activity, 1 hour after the activity, 24 hours after the activity, 48 hours after the activity, and 72 hours after the activity. In the non-exercising group blood was drawn from a vein one time.
Interventions
- OTHER control group
- OTHER Running
- OTHER Cycling
- OTHER Rugby
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2021-10-16 |
| Est. Completion | 2022-02-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06804291
The ClinicalTrials.gov registry entry for NCT06804291 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Appalachian State University, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which control group is the first listed.
NCT06804291 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06804291 about?
NCT06804291 is a clinical study titled "The Effect of Cycling, Running, and Playing Rugby on Three Biomarkers That May Indicate Brain Injury". The goal of this clinical trial was to determine if and how the biomarkers neurofilament light (NfL), brain lipid binding protein (BLBP), and amyloid precursor protein (APP) accumulated over 72 hours in venous blood following running, cycling, or playing rugby as compared to a non-exercising control...
What is the current status of trial NCT06804291?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2021-10-16. Estimated completion is 2022-02-15.
What interventions are being tested in trial NCT06804291?
The interventions under investigation include: control group (OTHER), Running (OTHER), Cycling (OTHER), Rugby (OTHER).
Who is sponsoring clinical trial NCT06804291?
This trial is sponsored by Appalachian State University, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.